Literature DB >> 21069534

Small deep white matter lesions are associated with right-to-left shunts in migraineurs.

Hee-Kwon Park1, Seo-Young Lee, Seong-Eun Kim, Chang-Ho Yun, Sung Hun Kim.   

Abstract

The right-to-left shunts (RLS) and white matter lesions (WMLs) are frequently observed in migraineurs and in patients with ischemic stroke. Previous studies have reported that the burden of WMLs did not increase with the intracardiac right-to-left shunt (RLS) in migraineurs. However, some types of WMLs are known to be associated with RLS in patients with stroke and dementia. The aim of the study was to demonstrate the difference in the size and location of WMLs, according to the existence of RLS in patients with headache. From the prospective headache registry, a total of 425 subjects (age, 30.8 ± 5.1 years; 303 women; 242 migraineurs; 183 patients with tension-type headache (TTH)) were retrospectively reviewed and evaluated for RLS and WMLs using M-mode power transcranial Doppler sonography (mTCD) and brain magnetic resonance imaging scans. We scored WMLs, according to the Rotterdam Scan Study, and assessed the association between RLS presence and the location and size of WMLs. The number of small deep WMLs (dWMLs) and the prevalence of RLS, defined as microembolic signals (MES) ≥ 11, were higher in patients with migraine (small dWMLs, 6.23 vs. 4.05; RLS, 36.8% vs. 10.9%), compared to patients with TTH. There was no significant difference in the sum of periventricular WML grades or the total volume of dWMLs between TTH and migraine patients. Among the migraineurs, the patients with RLS more frequently had small dWMLs, aura, and heart disease compared to those without RLS. In addition, RLS were also independent predictors for the presence of small dWMLs from the multivariate binary regression analysis (p < 0.01; OR = 3.24; 95%CI 1.56-6.72). Small dWMLs are associated with RLS in young migraineurs. These results imply that paradoxical embolism may cause the small WMLs in some migraineurs.

Entities:  

Mesh:

Year:  2010        PMID: 21069534     DOI: 10.1007/s00415-010-5771-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  30 in total

1.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

2.  White matter changes associated with deletions of the long arm of chromosome 18 (18q- syndrome): a dysmyelinating disorder?

Authors:  L A Loevner; R M Shapiro; R I Grossman; J Overhauser; J Kamholz
Journal:  AJNR Am J Neuroradiol       Date:  1996 Nov-Dec       Impact factor: 3.825

3.  BioSTAR Evaluation STudy (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts.

Authors:  Michael J Mullen; David Hildick-Smith; Joseph V De Giovanni; Christopher Duke; W Stewart Hillis; W Lindsay Morrison; Christian Jux
Journal:  Circulation       Date:  2006-10-24       Impact factor: 29.690

4.  Lack of association between migraine headache and patent foramen ovale: results of a case-control study.

Authors:  Pallav Garg; Stephen J Servoss; Justina C Wu; Zahid H Bajwa; Magdy H Selim; Alexis Dineen; Richard E Kuntz; E Francis Cook; Laura Mauri
Journal:  Circulation       Date:  2010-03-15       Impact factor: 29.690

5.  Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks.

Authors:  M Schwerzmann; S Wiher; K Nedeltchev; H P Mattle; A Wahl; C Seiler; B Meier; S Windecker
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

6.  Is migraine associated with right-to-left shunt a separate disease? Results of the SAM study.

Authors:  G P Anzola; G Meneghetti; C Zanferrari; A Adami; L Dinia; M Del Sette
Journal:  Cephalalgia       Date:  2008-02-14       Impact factor: 6.292

7.  Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study.

Authors:  M W Vernooij; A van der Lugt; M A Ikram; P A Wielopolski; W J Niessen; A Hofman; G P Krestin; M M B Breteler
Journal:  Neurology       Date:  2008-04-01       Impact factor: 9.910

8.  Migraine as a risk factor for subclinical brain lesions.

Authors:  Mark C Kruit; Mark A van Buchem; Paul A M Hofman; Jacobus T N Bakkers; Gisela M Terwindt; Michel D Ferrari; Lenore J Launer
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

9.  Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache.

Authors:  Andrew Dowson; Michael J Mullen; Richard Peatfield; Keith Muir; Arif Anis Khan; Christopher Wells; Susan L Lipscombe; Trevor Rees; Joseph V De Giovanni; W Lindsay Morrison; David Hildick-Smith; Giles Elrington; W Stewart Hillis; Iqbal S Malik; Anthony Rickards
Journal:  Circulation       Date:  2008-03-03       Impact factor: 29.690

10.  Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype.

Authors:  Giorgio Dalla Volta; Massimiliano Guindani; Paola Zavarise; Simona Griffini; Alessandro Pezzini; Alessandro Padovani
Journal:  J Headache Pain       Date:  2005-09       Impact factor: 7.277

View more
  10 in total

1.  Brain white matter lesions in migraine: what's the meaning?

Authors:  Bruno Colombo; D Dalla Libera; G Comi
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

2.  Cerebrovascular reactivity and deep white matter hyperintensities in migraine: A prospective CO2 targeting study.

Authors:  Mi Ji Lee; Bo-Yong Park; Soohyun Cho; Seonwoo Kim; Hyunjin Park; Sung Tae Kim; Chin-Sang Chung
Journal:  J Cereb Blood Flow Metab       Date:  2022-05-24       Impact factor: 6.960

3.  White matter lesions in chronic migraine with medication overuse headache: a cross-sectional MRI study.

Authors:  Zhenyang Zheng; Zijian Xiao; Xiaolei Shi; Minghui Ding; Wei Di; Weiwei Qi; Aiwu Zhang; Yannan Fang
Journal:  J Neurol       Date:  2014-02-18       Impact factor: 4.849

4.  Migraine, cerebrovascular disease and the metabolic syndrome.

Authors:  Alexandra J Sinclair; Manjit Matharu
Journal:  Ann Indian Acad Neurol       Date:  2012-08       Impact factor: 1.383

5.  Patients profiling for Botox® (onabotulinum toxin A) treatment for migraine: a look at white matter lesions in the MRI as a potential marker.

Authors:  Anja Bumb; Burkhard Seifert; Stephan Wetzel; Reto Agosti
Journal:  Springerplus       Date:  2013-08-10

6.  The relationship between right-to-left shunt and brain white matter lesions in Japanese patients with migraine: a single center study.

Authors:  Akio Iwasaki; Keisuke Suzuki; Hidehiro Takekawa; Ryotaro Takashima; Ayano Suzuki; Shiho Suzuki; Koichi Hirata
Journal:  J Headache Pain       Date:  2017-01-07       Impact factor: 7.277

7.  Right-to-left shunt and subclinical ischemic brain lesions in Chinese migraineurs: a multicentre MRI study.

Authors:  Xiao-Han Jiang; Si-Bo Wang; Qian Tian; Chi Zhong; Guan-Ling Zhang; Ya-Jie Li; Pan Lin; Yong You; Rong Guo; Ying-Hua Cui; Ying-Qi Xing
Journal:  BMC Neurol       Date:  2018-02-14       Impact factor: 2.474

8.  Small Demyelination of the Cortex May Be a Potential Marker for the Right-to-Left Shunt of the Heart.

Authors:  Junyan Huo; Mengxia Wan; Nan Li; Juan Wang; Xiao Cai; Dongsheng Fan; Yu Fu
Journal:  Brain Sci       Date:  2022-07-05

Review 9.  The Patent Foramen Ovale and Migraine: Associated Mechanisms and Perspectives from MRI Evidence.

Authors:  Wenfei Cao; Yinbo Shen; Jiaqi Zhong; Zhenhong Chen; Nizhuan Wang; Jiajun Yang
Journal:  Brain Sci       Date:  2022-07-18

10.  Evaluating the relationship between right-to-left shunt and white matter hyperintensities in migraine patients: A systematic review and meta-analysis.

Authors:  Joshua Y P Yeo; Claire X Y Goh; Ying Kiat Tan; Bryan T S Sim; Beverly L X Chan; Nicholas L Syn; Yinghao Lim; Amanda C Y Chan; Vijay K Sharma; Jonathan J Y Ong; Leonard L L Yeo; Ching-Hui Sia; Benjamin Y Q Tan
Journal:  Front Neurol       Date:  2022-08-18       Impact factor: 4.086

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.